Recombinant CCR4 (Mogamulizumab Biosimilar) antibody

Catalog No. ABIN7597833

This Humanized Chimeric antibody specifically detects CCR4 (Mogamulizumab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant CCR4 (Mogamulizumab Biosimilar) antibody (ABIN7597833)

Target: CCR4 (Mogamulizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CCR4 (Mogamulizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CCR4 (Mogamulizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Mogamulizumab Biosimilar Antibody

Specificity: K5-5, CCR4, C-C CKR-4, CD194, CC-CKR-4, CCR-4, C-C chemokine receptor type 4, CMKBR4

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.93 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CCR4 (Mogamulizumab Biosimilar)

Target: CCR4 (Mogamulizumab Biosimilar)

Alternative Name: Mogamulizumab Biosimilar

Target Type: Biosimilar

Background: K5-5, CCR4, C-C CKR-4, CD194, CC-CKR-4, CCR-4, C-C chemokine receptor type 4, CMKBR4

UniProt: P51679

CAS-No: 1159266-37-1